Members of free-to-join Target Circle can save on thousands of items including fall favorites, entertaining must-haves and get an early start on holiday shopping  The member-favorite Deal of the Day also returns with additional one-day-only deals Consumers who enroll in a Target Circle 360 annual membership during Target Circle Week will receive $50 off their next same-day delivery order of $50 or more MINNEAPOLIS, Sept. 26, 2024 /PRNewswire/ -- Target Corporation (NYSE: TGT) today announced that its bigges ...

Bayhorse Silver Announces Drill Program on Bayhorse Mine VTEM Anomaly for Potential Porphyry Copper TargetSeptember 25, 2024 9:28 AM EDT | Source: Bayhorse Silver Inc.Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - Bayhorse Silver Inc, (TSXV: BHS) (OTCQB: BHSIF) (FSE: 7KXN) (the "Company" or "Bayhorse") announces an underground diamond drill program to drill the large low-resistivity anomaly that extends from beneath the Company's silver/copper rich Bayhorse Silver Mine in ...

LyondellBasell Industries N.V. (LYB) stated that it has signed a power purchase agreement (PPA) with Eneco N.V.  This PPA brings LYB's total secured renewable power capacity to 100% of its renewable electricity procurement goal.LYB's electricity consumption constitutes approximately 15% of its 2020 baseline scope 1 and 2 greenhouse gas emissions. The company's objective of obtaining at least 50% of its electricity from renewable sources by 2030 is based on 2020 procurement levels.Under the 15-year PPA, LYB ...

– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other prevalent cardiovascular diseases driven by dysr ...

- Target Hospitality Board Disbands Special Committee -- Target Hospitality to Reinvigorate Focus on Allocating Capital to High Return Initiatives, Including In-Organic Growth -- Reaffirms 2024 Outlook Given Strength of Year-to-Date Operating Results -THE WOODLANDS, Texas, Sept. 25, 2024 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality," "Target" or the "Company") (Nasdaq: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality s ...

Key TakeawaysLevi Strauss posted a stylized image resembling Beyonce's "Cowboy Carter" album cover on Instagram that may hint at a collaboration with the superstar.Levi's CEO Michelle Gass reportedly pushed back the company's goal of reaching $9 billion to $10 billion in annual revenue by 2027.The company earlier this year reported $6.2 billion in revenue for its fiscal 2023. Levi Strauss & Co. (LEVI) hinted that a collaboration with superstar Beyonce may be on the horizon in an Instagram post on Monday. Th ...

Retailers are preparing for the holiday season with as much enthusiasm as shoppers looking for great deals. The season, which accounts for a sizable chunk of yearly revenues, is a make-or-break for retailers. To make the most of the festive season and win over early-bird shoppers, Target Corporation (TGT) is back with impressive deals and expanded product offerings.Target Circle Week: The Holiday KickoffTarget kicks off the holiday festivities with Target Circle Week, running from Oct. 6-12. This week-long ...

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute MyocarditisSeptember 24, 2024 7:27 AM EDT | Source: Cardiol Therapeutics Inc.Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it has achieved their target patient enrollment in the VIRAGE Phase 2b cl ...